1. Home
  2. ILAG vs CYCN Comparison

ILAG vs CYCN Comparison

Compare ILAG & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILAG
  • CYCN
  • Stock Information
  • Founded
  • ILAG N/A
  • CYCN N/A
  • Country
  • ILAG Hong Kong
  • CYCN United States
  • Employees
  • ILAG N/A
  • CYCN N/A
  • Industry
  • ILAG Office Equipment/Supplies/Services
  • CYCN Biotechnology: Pharmaceutical Preparations
  • Sector
  • ILAG Consumer Discretionary
  • CYCN Health Care
  • Exchange
  • ILAG Nasdaq
  • CYCN Nasdaq
  • Market Cap
  • ILAG 14.0M
  • CYCN 7.8M
  • IPO Year
  • ILAG 2022
  • CYCN N/A
  • Fundamental
  • Price
  • ILAG $0.83
  • CYCN $3.31
  • Analyst Decision
  • ILAG
  • CYCN
  • Analyst Count
  • ILAG 0
  • CYCN 0
  • Target Price
  • ILAG N/A
  • CYCN N/A
  • AVG Volume (30 Days)
  • ILAG 213.0K
  • CYCN 9.9K
  • Earning Date
  • ILAG 07-30-2024
  • CYCN 07-26-2024
  • Dividend Yield
  • ILAG N/A
  • CYCN N/A
  • EPS Growth
  • ILAG N/A
  • CYCN N/A
  • EPS
  • ILAG N/A
  • CYCN N/A
  • Revenue
  • ILAG $6,443,357.00
  • CYCN N/A
  • Revenue This Year
  • ILAG N/A
  • CYCN N/A
  • Revenue Next Year
  • ILAG N/A
  • CYCN N/A
  • P/E Ratio
  • ILAG N/A
  • CYCN N/A
  • Revenue Growth
  • ILAG N/A
  • CYCN N/A
  • 52 Week Low
  • ILAG $0.33
  • CYCN $1.75
  • 52 Week High
  • ILAG $1.20
  • CYCN $5.25
  • Technical
  • Relative Strength Index (RSI)
  • ILAG 83.32
  • CYCN 58.45
  • Support Level
  • ILAG $0.49
  • CYCN $2.50
  • Resistance Level
  • ILAG $0.58
  • CYCN $3.92
  • Average True Range (ATR)
  • ILAG 0.09
  • CYCN 0.53
  • MACD
  • ILAG 0.04
  • CYCN 0.07
  • Stochastic Oscillator
  • ILAG 70.00
  • CYCN 66.84

About ILAG Intelligent Living Application Group Inc.

Intelligent Living Application Group Inc is engaged in the business of manufacturing and selling mechanical locksets. The business is spread across the Unites States, Canada, Australia, and China. Majority of the revenue is generated from the United States.

About CYCN Cyclerion Therapeutics Inc.

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

Share on Social Networks: